Genomic instability, a hallmark of almost all cancers, originates from the combined effects of a deregulated DNA damage response, DNA repair defects, and a failure of cell-cycle checkpoints before the damaged DNA is propagated to daughter cells [1]. Alterations in this network of genomic integrity-preserving pathways lead to the accumulation of mutations, aneuploidy, and chromosomal alterations, the main causes of cancer. Multiple myeloma (MM) is a clonal malignancy of terminally differentiated plasma cells that reside and expand in the bone marrow. MM cells are characterized by a high aneuploidy incidence and recurrent structural chromosomal alterations, features that reflect these cells' underlying genomic instability [2]
Multiple Myeloma (MM) is characterized by uncontrolled proliferation and accumulation of clonal plas...
International audienceBACKGROUND: Multiple myeloma (MM) is a malignant proliferation of plasma B cel...
Multiple myeloma (MM) is characterized by malignancy of terminally differentiated B-lymphocytes. Ide...
Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests la...
Background: Multiple myeloma (MM) is a plasma cells malignancy charac- terized by a complex and hete...
Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal plasma cell...
Multiple myeloma (MM) is an exceptionally complicated and heterogeneous disease that is caused by th...
Multiple myeloma (MM) is a genetically heterogeneous disease, in which the process of tumorigenesis ...
Copyright © 2015 Antonia Cagnetta et al. This is an open access article distributed under the Creati...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
International audienceMultiple myeloma (MM) is a malignancy characterized by accumulation of maligna...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Genomic aberrations comprise hallmarks of multiple myeloma (MM), a plasma cell malignancy with an ov...
Multiple myeloma (MM), is the second most common blood cancer after non-Hodgkin’s lymphoma. Genetic ...
Multiple Myeloma (MM) is characterized by uncontrolled proliferation and accumulation of clonal plas...
International audienceBACKGROUND: Multiple myeloma (MM) is a malignant proliferation of plasma B cel...
Multiple myeloma (MM) is characterized by malignancy of terminally differentiated B-lymphocytes. Ide...
Ongoing genomic instability represents a hallmark of multiple myeloma (MM) cells, which manifests la...
Background: Multiple myeloma (MM) is a plasma cells malignancy charac- terized by a complex and hete...
Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal plasma cell...
Multiple myeloma (MM) is an exceptionally complicated and heterogeneous disease that is caused by th...
Multiple myeloma (MM) is a genetically heterogeneous disease, in which the process of tumorigenesis ...
Copyright © 2015 Antonia Cagnetta et al. This is an open access article distributed under the Creati...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
<div><p>Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abn...
International audienceMultiple myeloma (MM) is a malignancy characterized by accumulation of maligna...
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormaliti...
Genomic aberrations comprise hallmarks of multiple myeloma (MM), a plasma cell malignancy with an ov...
Multiple myeloma (MM), is the second most common blood cancer after non-Hodgkin’s lymphoma. Genetic ...
Multiple Myeloma (MM) is characterized by uncontrolled proliferation and accumulation of clonal plas...
International audienceBACKGROUND: Multiple myeloma (MM) is a malignant proliferation of plasma B cel...
Multiple myeloma (MM) is characterized by malignancy of terminally differentiated B-lymphocytes. Ide...